|
From our offices in Munich, we’re able to provide clinical monitoring throughout the German-speaking parts of Europe – Germany, Austria and parts of Switzerland
– as well as contribute to large, multinational trials that Kendle conducts. With a combined population of approximately 95 million and highly-developed medical systems, the region is not only one of the largest pharmaceutical markets in the world, but is also very attractive for conducting clinical trials in almost every indication and every phase of drug development.
Our Munich offices provide comprehensive Phase II–IV clinical services such as protocol design, feasibility and site selection, regulatory document collection, monitoring and site management, project management, resourcing, clinical quality assurance, clinical data management, statistics, medical writing, information technologies, post marketing surveillance and health economic/outcomes research services. For many years Kendle has been providing professional training in Munich on various topics related to clinical research as part of our corporate training and development division, Kendle College. |
